Christian Dimaano

Christian Dimaano serves as the Vice President and Head of Global Medical Affairs at Geron Corporation, focusing on strategy and operations for a novel telomerase inhibitor in hematologic malignancies. Dimaano holds a position as a Clinical Associate Professor at the University of Washington in the Department of Health Systems & Population Health. Previous roles include Vice President of Medical Affairs at Lassen Therapeutics and Kinnate Biopharma Inc., and Executive Director at Mirati Therapeutics, where oversight of various Medical Affairs functions was key. Dimaano has extensive experience in the pharmaceutical industry, holding leadership roles at Astellas Pharma and Gilead Sciences, as well as serving as adjunct faculty at various institutions. Educational qualifications include a Ph.D. in Oncological Sciences and a Master of Public Health, along with degrees in Biological Science and Biology.